Cerevance Media Center

Current News

July 21, 2020

Cerevance Expands Series B Financing to $65 Million

Cerevance, a private drug discovery and development company focused on brain diseases, has expanded its Series B financing round, adding $20 million to the $45 million that it announced in April.

READ FULL

April 14, 2020

Cerevance Closes $45 Million Series B Financing

Cerevance has closed a Series B financing, bringing in $45 million from new investors including GV (formerly Google Ventures), Bill Gates and Foresite Capital, as well as all of the company’s previous investors...

READ FULL

January 7, 2020

Cerevance Appoints Clinical Development Veteran Dr. Aoife Brennan to Board of Directors

Dr. Brennan is currently president and chief executive officer of Synlogic, Inc. (Nasdaq:SYBX), a clinical stage biotechnology company applying synthetic biology to beneficial microbes to develop novel, living medicines.

READ FULL

December 17, 2019

Cerevance Enters Research Collaboration with Takeda to Advance New Treatments for Gastrointestinal Disorders

Cerevance has formed a multi-year research alliance with Takeda Pharmaceutical Company Limited (“Takeda”) to identify novel target proteins expressed in the central nervous system and to develop new therapies against them for certain GI disorders.

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

May 16, 2023

Phase 1 Data on CVN766 at American Society of Clinical Psychopharmacology (ASCP)

Date:
Tuesday, May 30, 2023
Time:
2:00pm – 4:00pm
Location:
Miami, Florida
Media:
Oral Presentation
Read full

May 9, 2023

Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development

Date:
Monday, May 15, 2023
Time:
Check schedule for times
Location:
British Columbia, Canada
Media:
Presentation
Read full

May 8, 2023

2023 RBC Capital Markets Global Healthcare Conference

Date:
Tuesday, May 16, 2023
Time:
9:00 – 9:25am ET
Location:
New York, NY
Media:
Presentation
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

August 14, 2023

A Covalent Binding Mode of a Pyrazole-Based CD38 Inhibitor

Doyle, K., Roberts, M., Harvey, J, Hewer, R., Zebisch, M., Rangel, V., Gu, M., Wu, Y., Yang, L., Carlton, M., Dawson, L. & Bürli, R.

Viewview

October 15, 2018

Species and Cell-Type Properties of Classically Defined Human and Rodent Neurons and Glia

Xu, X., Stoyanova, E.I., Lemiesz, A.E., Xing, J., Mash, D.C., Heintz, N.

Viewview